Outset Medical, Inc.
OM
$14.20
$0.533.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.47% | -7.84% | -12.80% | -13.00% | -9.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.47% | -7.84% | -12.80% | -13.00% | -9.94% |
| Cost of Revenue | -9.50% | -21.92% | -26.68% | -25.21% | -21.24% |
| Gross Profit | 32.36% | 34.49% | 35.44% | 35.41% | 40.28% |
| SG&A Expenses | -28.18% | -25.62% | -21.90% | -17.10% | -6.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.28% | -28.36% | -26.56% | -21.70% | -12.00% |
| Operating Income | 49.37% | 44.64% | 37.30% | 28.37% | 13.58% |
| Income Before Tax | 38.55% | 32.63% | 26.00% | 19.89% | 6.57% |
| Income Tax Expenses | -22.31% | -9.94% | -6.12% | 27.79% | 24.94% |
| Earnings from Continuing Operations | 38.50% | 32.56% | 25.94% | 19.76% | 6.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.50% | 32.56% | 25.94% | 19.76% | 6.50% |
| EBIT | 49.37% | 44.64% | 37.30% | 28.37% | 13.58% |
| EBITDA | 51.01% | 46.15% | 38.59% | 29.41% | 14.27% |
| EPS Basic | 56.94% | 42.34% | 28.79% | 22.68% | 10.35% |
| Normalized Basic EPS | 61.30% | 45.94% | 32.56% | 25.25% | 12.82% |
| EPS Diluted | 56.94% | 42.34% | 28.79% | 22.68% | 10.35% |
| Normalized Diluted EPS | 61.30% | 45.94% | 32.56% | 25.25% | 12.82% |
| Average Basic Shares Outstanding | 134.05% | 30.33% | 4.10% | 3.83% | 4.48% |
| Average Diluted Shares Outstanding | 134.05% | 30.33% | 4.10% | 3.83% | 4.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |